The prognostic utility of cardiopulmonary exercise testing stands the test of time in patients with heart failure

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 32, Issue 4, 2012, Pages 198-202

  Arena, Ross ^a,b   Guazzi, Marco ^c   Myers, Jonathan ^d   Chase, Paul ^e   Bensimhon, Daniel ^e   Cahalin, Lawrence P ^f   Peberdy, Mary Ann ^g   Ashley, Euan ^h   West, Erin ⁱ   Forman, Daniel E ⁱ  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e LeBauer Cardiovascular Research Foundation   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Expired gas; Heart disease; Survival; Ventilation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON DIOXIDE;

ADULT; AGE DISTRIBUTION; AIR CONDITIONING; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ASSESSMENT; DISEASE SEVERITY; FEMALE; GENDER; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC HEART FAILURE;

CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PROGNOSIS; TIME;

EID: 84866033872     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0b013e318259f153     Document Type: Article

References (15)

1. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson Jr. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778-786.
2. Corra U, Piepoli MF. Official document on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction - recommendations for performance and interpretation. Monaldi Arch Chest Dis. 2007;68:6-12.
3. Poggio R, Arazi HC, Giorgi M, Miriuka SG. Prediction of severe cardiovascular events by VE/VCO2 slope versus peak VO2 in systolic heart failure: A meta-analysis of the published literature. Am Heart J 2010;160:1004-1014.
4. Balady GJ, Arena R, Sietsema K, et al. Clinician's guide to cardiopulmonary exercise testing in adults. A scientific statement from the American Heart Association. Circulation. 2010;122: 191-225.
5. O'Neill JO, Young JB, Pothier CE, Lauer MS. Peak oxygen consumption as a predictor of death in patients with heart failure receiving -blockers. Circulation. 2005;111:2313-2318.
6. Arena RA, Guazzi M, Myers J, Abella J. The prognostic value of ventilatory efficiency with beta-blocker therapy in heart failure. Med Sci Sports Exerc. 2007;39:213-219.
7. Radford MJ, Arnold JM, Bennett SJ, et al. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure. Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. Circulation 2005;112:18818-18916.
8. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. Circulation. 2005;112:e154-e235.
9. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA guidelines for exercise testing. J Am Coll Cardiol. 1997;30:260-311.
10. Gibbons RJ, Balady GJ, Timothy BJ, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. J Am Coll Cardiol. 2002;40:1531-1540.
11. Piepoli MF, Corra U, Agostoni PG, et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part II: how to perform cardiopulmonary exercise testing in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2006;13:300-311.
12. Piepoli MF, Corra U, Agostoni PG, et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part I: definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2006;13:150-164.
13. Piepoli MF, Corra U, Agostoni PG, et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part III: interpretation of cardiopulmonary exercise testing in chronic heart failure and future applications. Eur J Cardiovasc Prev Rehabil. 2006;13:485-494.
14. Arena R, Myers J, Guazzi M. The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review. Heart Fail Rev. 2008;13: 245-269.
15. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics - 2012 update: A report from the American Heart Association. Circulation. 2012;125:e2-e220.